Highest ROI Supplements

GLP-1s are not weak drugs.

They are powerful enough to change appetite, food reward, glucose regulation, gastric emptying, body weight, body composition, and long-term cardiometabolic risk. But that power creates a new problem: the limiting factor is often no longer “does the drug work?” The limiting factor is whether the patient can tolerate the drug long enough, eat intelligently enough, preserve enough lean mass, and avoid the side-effect loops that make people quit. This is the same core idea as the reference pieces: once a field has a powerful intervention, the next frontier is not just more force — it is better control.

The common side effects are not rare edge cases. In adult Wegovy trials, nausea occurred in 44% of treated patients versus 16% on placebo, diarrhea in 30% versus 16%, vomiting in 24% versus 6%, constipation in 24% versus 11%, abdominal pain in 20% versus 10%, fatigue in 11% versus 5%, dyspepsia in 9% versus 3%, abdominal distension in 7% versus 5%, eructation in 7% versus less than 1%, and flatulence in 6% versus 4%. Wegovy’s label also reports that GI adverse reactions were a major reason for treatment discontinuation.¹

Zepbound has a similar pattern. In pooled adult obesity/overweight trials, nausea occurred in 25–29% depending on dose versus 8% on placebo, diarrhea in 19–23% versus 8%, vomiting in 8–13% versus 2%, constipation in 11–17% versus 5%, dyspepsia in 9–10% versus 4%, and fatigue in 5–7% versus 3%. Lilly’s prescribing information also notes that most nausea, vomiting, and diarrhea events occur during dose escalation and decrease over time.²

So the supplement stack should not be random.

It should target the real bottlenecks:

muscle loss, nausea, vomiting, constipation, reflux/dyspepsia, dehydration, fatigue, and adherence.

---

The One-Sentence Thesis

The highest ROI GLP-1 supplement stack is not designed to make the drug “stronger.”

It is designed to make the weight loss cleaner:

less nausea, less constipation, less dehydration, less lean-mass loss, less fatigue, and fewer people quitting before the drug has time to work.

---

HMB

The Most Underrated Anti-Catabolic Tool

Protein powder is obvious.

HMB is the underrated one.

The standard advice for GLP-1 patients is: “Eat more protein.” That is correct, but it ignores the actual patient experience. Many people on semaglutide or tirzepatide do not fail protein targets because they are lazy. They fail because the drug makes food physically difficult: early satiety, nausea, reflux, delayed gastric emptying, food aversion, constipation, and meal fatigue all reduce intake. This is exactly where HMB becomes interesting.

HMB, or β-hydroxy-β-methylbutyrate, is a metabolite of leucine. Leucine is one of the key amino acids in high-protein diets, and HMB is one of the downstream molecules that helps explain why leucine-rich protein can be muscle-protective. Human physiology research suggests HMB can stimulate muscle protein synthesis while also reducing muscle protein breakdown, making it different from ordinary protein substrate alone.³

That distinction matters.

Protein is substrate. HMB is signal.

Protein gives the body amino acids to build and maintain tissue. HMB is more specifically interesting because it may reduce muscle breakdown through proteolytic pathways, including the ubiquitin-proteasome and autophagy-lysosome systems that are involved in catabolic muscle loss. That is why HMB is not just “weaker protein.” It is a different kind of muscle-preservation tool.

This matters on GLP-1s because the baseline lean-mass issue is real. In tirzepatide body-composition analyses, approximately 75% of body weight lost was fat mass and 25% was lean mass.⁴

That creates a simple baseline model:

Total weight lost	Expected lean mass lost if 25% is lean mass
20 lb	5 lb
40 lb	10 lb
60 lb	15 lb
80 lb	20 lb

This does not mean all “lean mass” is skeletal muscle. Lean mass also includes water, glycogen, connective tissue, and organ-associated mass. But clinically, losing too much lean mass can still matter because it may reduce strength, training capacity, resting energy expenditure, physical function, and long-term metabolic resilience.

Why HMB may be higher ROI than protein in the worst GLP-1 weeks

In normal circumstances, protein is more foundational. But during dose escalation, nausea weeks, or appetite-collapse windows, HMB can be more practical because it does not require a meal.

To get a strong leucine signal from food, a patient often needs something like:

Source	Approximate intake needed for a meaningful leucine pulse
Whey protein	~25–30 g protein
Chicken / fish / beef	~30–40 g protein
Eggs	~4–5 eggs
Greek yogurt	often 1.5–2 cups depending on brand

For a normal lifter, that is easy.

For a GLP-1 patient who feels full after six bites, it can be unrealistic.

HMB’s standard dose is usually 3 g/day, often split as 1 g three times daily or 1.5 g twice daily. That is the ingestion burden advantage: HMB gives an anti-catabolic signal without requiring the stomach volume of a high-protein meal.

Quantified expectation

The honest estimate is that HMB is not going to erase GLP-1 lean-mass loss by itself. But in high-risk patients — older adults, low baseline muscle, rapid weight loss, poor protein tolerance, nausea-prone patients, and people not yet lifting — HMB may plausibly preserve ~0.5–2 lb of lean mass over several months, with larger upside if baseline catabolic risk is high.

A 2022 meta-analysis specifically examined HMB-enriched nutritional supplements in obese adults during weight-loss therapy, which is highly relevant to GLP-1 physiology even though it is not a direct GLP-1 trial.³ Other meta-analytic work in sarcopenic or older adults suggests HMB may improve some muscle outcomes, especially handgrip strength, though not every body-composition measure improves consistently.⁵

Best protocol

Dose: 3 g/day Timing: 1 g morning, 1 g afternoon, 1 g evening Best use window: dose escalation, nausea weeks, low-protein weeks, rapid weight-loss phases Best pairing: HMB + creatine + protein floor + resistance training Best phenotype: “I cannot eat enough, but I do not want to lose muscle.”

BOTB verdict

HMB is the most underrated GLP-1 supplement because it targets the exact failure mode protein powder does not solve: the patient who cannot physically eat enough protein.

---

Creatine Monohydrate

The Training-Signal Preserver

Creatine does not directly treat nausea, constipation, reflux, or vomiting.

Its job is different: keep the patient strong enough to send the body a “preserve muscle” signal.

During GLP-1 weight loss, the body is in an energy deficit. If the patient also stops lifting, reduces steps, eats too little protein, and feels fatigued, the body has fewer reasons to defend muscle. Creatine helps because it increases intramuscular phosphocreatine availability, improving rapid ATP regeneration during high-intensity effort. In practice, that means better reps, better training quality, and a stronger mechanical retention signal.

A meta-analysis in older adults found that creatine supplementation during resistance training increased lean tissue mass and improved upper- and lower-body strength.⁶ This is not direct GLP-1 evidence, but the mechanism maps cleanly onto the GLP-1 problem: if weight loss threatens muscle, preserve the training signal.

Quantified expectation

Creatine’s benefit is modest but meaningful. Over months, especially when paired with resistance training, a realistic expectation is ~1–3 lb better lean-mass or lean-tissue outcome compared with training without creatine, though part of the scale change may reflect intracellular water rather than new contractile muscle.

That water effect is not bad. It may actually be useful. A patient may see the scale stall or rise 1–3 lb after starting creatine, but that is usually not fat gain. It is often increased muscle water/glycogen-associated mass.

Best protocol

Dose: 3–5 g/day creatine monohydrate Loading: skip loading if GI-sensitive Timing: any time daily Best pairing: resistance training 3–4×/week Caution: kidney disease or abnormal kidney labs should be clinician-guided.

BOTB verdict

Creatine is the highest ROI performance-preservation supplement. HMB protects against breakdown; creatine helps preserve the training signal. Together, they are more logical than either alone.

---

Protein Powder

Still Foundational, Just Not Always Feasible

Protein powder is still essential. It is just not always the most underrated.

Higher protein intake helps preserve lean mass during weight loss, especially when paired with resistance training. Reviews of weight-loss interventions in overweight or obese adults consistently support higher protein intake as a lean-mass preservation strategy, and enhanced protein intake above roughly 1.0–1.3 g/kg/day appears more protective than lower intake during weight loss.⁷

The problem is compliance.

GLP-1 patients often know they need protein. They just cannot always tolerate enough whole food. Protein powder helps because it compresses protein into a smaller, easier format than a full meal.

Best protocol

Dose: 25–40 g protein per serving Frequency: 1–2× daily as needed Best form: whey isolate or hydrolysate if dairy-tolerant; plant blend if not Target: often 100–160 g/day total protein for many adults, adjusted by size, kidney status, training, and clinician guidance

Quantified expectation

If baseline lean-mass loss is around 25% of total weight lost, then a patient losing 40 lb might lose around 10 lb lean mass on average. A strong protein + resistance-training protocol may plausibly move that closer to 4–8 lb, depending on age, baseline muscle, training quality, dose intensity, and rate of weight loss. This is extrapolated from weight-loss and resistance-training literature, not proven as a precise GLP-1-specific number.

BOTB verdict

Protein is the foundation. HMB is the compliance hack. Creatine is the performance amplifier. The stack works because each piece solves a different muscle-loss mechanism.

---

Psyllium Husk

The Constipation Circuit Breaker

Constipation is not a minor GLP-1 side effect.

It can become the root cause of everything else.

The loop looks like this:

slower motility → constipation → bloating → reflux → nausea → lower intake → dehydration → worse constipation

That loop can make a patient think they “cannot tolerate GLP-1s” when the actual bottleneck is stool transit.

Constipation occurred in 24% of Wegovy-treated adults versus 11% on placebo, and in 11–17% of Zepbound-treated adults versus 5% on placebo.¹

Psyllium is one of the highest ROI tools here because it has actual constipation data. A 2022 systematic review and meta-analysis found that fiber supplementation improved chronic constipation, with 66% responding to fiber versus 41% responding to control. Psyllium, doses above 10 g/day, and durations of at least 4 weeks appeared especially effective, although heterogeneity was substantial and flatulence can increase.⁸

Mechanism

Psyllium is a soluble, gel-forming fiber. It holds water, improves stool bulk, softens stool consistency, and can normalize bowel patterns. On GLP-1s, this is especially useful because slower GI transit plus lower food volume can reduce stool frequency.

Best protocol

Start: 3–5 g/day Target: 8–10+ g/day if tolerated Timing: away from medications when possible Mandatory: enough water Avoid: aggressive dosing on day one — that can worsen bloating.

Quantified expectation

GLP-1-specific psyllium trials are lacking, so we cannot honestly say “psyllium reduces Wegovy constipation from 24% to X%.” But using chronic constipation data, the practical expectation is a moderate-to-large improvement in stool frequency and stool consistency in constipation-prone patients.

A reasonable clinical estimate:

Baseline issue	Expected psyllium effect
Mild constipation	high chance of improvement
Hard stools	high
Low stool frequency	moderate-high
Severe constipation with bloating	helpful, but may need magnesium/PEG/medical support
Diarrhea-prone patient	may not be appropriate

BOTB verdict

Psyllium is not optional if constipation is the bottleneck. It is the first-line supplement-level tool for preventing the constipation → reflux → nausea cascade.

---

Magnesium Oxide / Magnesium Citrate

The Stool-Water Lever

Psyllium builds structure.

Magnesium pulls water.

That makes magnesium a different constipation tool.

Magnesium oxide has randomized controlled trial evidence in chronic constipation. A double-blind placebo-controlled trial found magnesium oxide improved defecation status and shortened colonic transit time in patients with chronic constipation.⁹

Mechanism

Magnesium salts act osmotically. They retain water in the intestinal lumen, soften stool, and make bowel movements easier. This is especially relevant for GLP-1 constipation when the stool is hard, dry, and infrequent.

Best protocol

Magnesium oxide: commonly used for constipation; dose should be conservative and adjusted to response Magnesium citrate: often stronger, more likely to loosen stool Timing: evening works well for many people Avoid/caution: kidney disease, dehydration, electrolyte disorders, older frail patients, or unclear abdominal pain.

Quantified expectation

Magnesium is best thought of as a targeted tool, not a universal daily supplement.

Symptom pattern	Expected ROI
Hard stool + low frequency	very high
Mild constipation	high
Bloating without hard stool	mixed
Diarrhea-prone	low / negative
Kidney disease	avoid unless clinician-approved

BOTB verdict

Magnesium is the constipation rescue lever. Psyllium normalizes stool architecture; magnesium fixes stool dryness.

---

Ginger Extract

The Nausea Tool With Real but Indirect Evidence

Nausea is the iconic GLP-1 side effect.

It is also one of the main reasons people under-eat, skip protein, avoid meals, and stop dose escalation. In Wegovy trials, nausea occurred in 43.9–44% of patients versus about 16% on placebo; in Zepbound trials, nausea occurred in 25–29% versus 8% on placebo.¹

Ginger is not proven specifically for semaglutide/tirzepatide nausea. But it has evidence in other nausea contexts. A meta-analysis of chemotherapy-induced nausea/vomiting found ginger reduced acute chemotherapy-induced nausea/vomiting with an odds ratio of 0.60, especially for acute vomiting.¹⁰ Another review found ginger did not consistently reduce every chemotherapy nausea endpoint, so the evidence is real but mixed.¹¹

Mechanism

Ginger compounds such as gingerols and shogaols may influence GI motility, serotonin-related nausea signaling, cholinergic pathways, and visceral sensitivity. This makes it mechanistically plausible for GLP-1 nausea, which likely involves both central nausea pathways and gut-brain/vagal signaling.

Best protocol

Dose: 500 mg ginger extract 1–2× daily Timing: morning, pre-meal, or around injection-day symptom window Upper range: often 1–2 g/day; be cautious above that Caution: reflux-prone patients may feel burning; caution with anticoagulants or bleeding risk.

Quantified expectation

Baseline nausea:

Drug	Nausea rate
Wegovy	~44%
Zepbound	~25–29%

A conservative extrapolated estimate: ginger may reduce nausea severity/frequency by ~10–30% relative in responders, but this is not GLP-1-specific. So if a patient’s baseline nausea risk is 40%, ginger might plausibly move the experienced burden to something like 30–36% equivalent severity/frequency, not eliminate it.

BOTB verdict

Ginger is the highest ROI supplement-level nausea tool, but it should be framed honestly: plausible, low-cost, mixed evidence, not a guaranteed antiemetic.

---

Electrolytes / Oral Rehydration Solution

The Dehydration and Fatigue Backstop

Electrolytes do not directly “treat GLP-1 nausea.”

They treat the downstream failure state: low fluid intake, vomiting, diarrhea, dizziness, fatigue, orthostatic symptoms, and kidney stress from volume depletion.

Wegovy’s patient safety information warns that nausea, vomiting, and diarrhea can cause dehydration and kidney problems.¹² Zepbound labeling also warns about acute kidney injury due to volume depletion, often in the setting of GI adverse reactions causing dehydration.²

Oral rehydration therapy is a first-line treatment to compensate for fluid losses from diarrhea and vomiting. It works because sodium and glucose co-transport helps drive water absorption, which is why a properly formulated oral rehydration solution can hydrate better than plain water during GI fluid loss.¹³

Best protocol

Use during:

• vomiting
• diarrhea
• very low intake
• dizziness
• heat exposure
• heavy sweating
• injection-week nausea
• constipation worsened by low fluid intake

Protocol: sip slowly; do not chug if nauseous. Look for: sodium + potassium + small amount of glucose/carbs. Caution: diabetes, hypertension, kidney disease, heart failure, or sodium restrictions require clinician guidance.

Quantified expectation

Electrolytes will not reduce nausea from 44% to 20%. That is not their job.

Their job is to reduce the probability that nausea/vomiting/diarrhea turns into:

• dehydration
• dizziness
• headache
• fatigue
• constipation worsening
• acute kidney stress
• treatment interruption

BOTB verdict

Electrolytes are boring until they prevent the side effect spiral. During vomiting, diarrhea, or low intake, they become Tier 1.

---

Peppermint Oil + Caraway Oil

The Bloating / Dyspepsia / Upper-GI Pressure Tool

Some GLP-1 patients do not describe their problem as nausea.

They describe:

• burping
• bloating
• upper abdominal pressure
• reflux
• dyspepsia
• “food sitting in my stomach”
• discomfort after small meals

This matters because GLP-1s delay gastric emptying and commonly cause upper-GI symptoms. Wegovy lists dyspepsia, abdominal distension, eructation, GERD, and flatulence among common reactions; Zepbound lists dyspepsia, eructation, and GERD among common reactions.¹

Peppermint oil + caraway oil has evidence in functional dyspepsia. A systematic review/meta-analysis found the combination was effective and safe as a short-term treatment for functional dyspepsia; the full analysis reported clinically meaningful symptom improvement versus placebo, though evidence quality was limited by study size and heterogeneity.¹⁴

Mechanism

Peppermint oil can relax GI smooth muscle through calcium-channel effects, while caraway oil may have antispasmodic, carminative, and motility-modulating effects. In GLP-1 patients, this is most relevant when the issue is pressure, spasm, bloating, or dyspepsia rather than true acid reflux.

Best protocol

Use: enteric-coated or duodenal-release peppermint/caraway product Timing: before meals or during dyspepsia windows Avoid/caution: peppermint may worsen GERD in some patients by relaxing the lower esophageal sphincter.

Quantified expectation

For functional dyspepsia, published analyses suggest meaningful short-term symptom improvement, but for GLP-1 dyspepsia specifically, there is no direct RCT. A reasonable estimate is:

Symptom	Expected utility
Bloating	medium-high
Dyspepsia	high
Burping/upper pressure	medium-high
Nausea	medium
True GERD/heartburn	mixed; may worsen

BOTB verdict

Peppermint/caraway is a high-ROI niche pick for the bloating/dyspepsia phenotype, but not the best choice for classic acid reflux.

---

Fiber + Fluids vs Diarrhea

The Forgotten Opposite Problem

Constipation gets most of the attention, but diarrhea is also common.

In Wegovy adult trials, diarrhea occurred in 30% versus 16% placebo. In Zepbound trials, diarrhea occurred in 19–23% versus 8% placebo.¹

The mistake is using the same GI stack for everyone. A constipation-prone patient may benefit from psyllium and magnesium. A diarrhea-prone patient may get worse with magnesium citrate.

For diarrhea-prone patients, the first supplement-level move is often oral rehydration/electrolytes, not laxative-style interventions. Psyllium can sometimes help normalize stool consistency because it is gel-forming, but dosing must be conservative.

Best protocol

First-line: ORS/electrolytes Optional: low-dose psyllium if watery stools persist and patient tolerates fiber Avoid: magnesium citrate, aggressive fiber loading, sugar alcohols, high-fat meals Medical escalation: persistent diarrhea, blood, fever, severe pain, dehydration, or kidney-risk symptoms.

Quantified expectation

No supplement has strong GLP-1-specific diarrhea prevention data. But hydration support is strongly mechanistic and clinically standard for diarrhea/vomiting fluid loss.¹³

BOTB verdict

For diarrhea, the supplement stack flips: electrolytes first, psyllium cautiously, magnesium usually no.

---

Vitamin D

Deficiency Correction, Not Magic

Vitamin D is not a GLP-1 side-effect antidote.

But it matters if the patient is deficient, older, low-muscle, low-sunlight, low-dairy, or at risk for poor bone/muscle function during rapid weight loss. Vitamin D’s effects on muscle are inconsistent in people who are already replete, but deficiency correction remains clinically important.

The best framing is:

Vitamin D is high ROI if deficient and low ROI if already replete.

Best protocol

Test: 25(OH)D Common dose: 1,000–2,000 IU/day D3, adjusted to labs Higher doses: clinician-guided Best pairing: protein + resistance training + creatine/HMB if muscle preservation is the goal

Quantified expectation

Vitamin D status	Expected ROI
Deficient	high
Insufficient	moderate
Replete	low
Blind high-dose use	not smart

BOTB verdict

Vitamin D is not a BOTB universal GLP-1 supplement. It is a BOTB correction if labs show deficiency.

---

Omega-3 Fatty Acids

Cardiometabolic Support, Not Core Side-Effect Mitigation

Omega-3s are useful, but they are not the main GLP-1 side-effect tool.

They may support triglycerides, inflammation, and possibly muscle anabolic sensitivity in certain populations, but evidence for direct GLP-1 nausea, constipation, reflux, or muscle-loss prevention is weak. Reviews of omega-3 and skeletal muscle suggest potential relevance to muscle protein turnover and anabolic response, but the evidence is mixed and population-dependent.¹⁵

Best protocol

Dose: 1–2 g/day combined EPA+DHA Best use case: high triglycerides, low fish intake, inflammatory phenotype Caution: fishy reflux, anticoagulants, bleeding risk, GI upset

Quantified expectation

Target	Expected ROI
Triglycerides	medium-high
Inflammation	modest
Muscle preservation	low-moderate, indirect
Nausea	low
Constipation	low

BOTB verdict

Omega-3 is a good general health supplement. It is not a core GLP-1 side-effect mitigation supplement.

---

The Quantitative Stack Model

Baseline GLP-1 side effect rates

Side effect	Wegovy adult trials	Zepbound adult trials
Nausea	~44%	25–29%
Diarrhea	~30%	19–23%
Vomiting	~24%	8–13%
Constipation	~24%	11–17%
Dyspepsia	~9%	9–10%
Fatigue	~11%	5–7%
Lean mass fraction of weight lost	not same table	~25% in tirzepatide body-comp analysis

Sources: Wegovy prescribing information / STEP GI tolerability analysis, Zepbound prescribing information, tirzepatide body-composition analysis.¹

---

Expected Effects by Supplement

These are not guarantees. They are practical expectation ranges based on direct evidence where available and extrapolation where GLP-1-specific evidence does not exist.

Supplement	Primary target	Evidence strength	Expected practical effect
HMB	Lean mass / catabolism	moderate, indirect	may preserve ~0.5–2 lb lean mass over months; higher upside in high-risk patients
Creatine	Strength / training output	strong for training, indirect for GLP-1	may improve lean/strength outcome ~1–3 lb equivalent over months
Protein powder	Lean mass / fatigue	strong for weight-loss muscle preservation	may reduce lean-loss fraction when paired with training
Psyllium	Constipation	strong for constipation, indirect GLP-1	chronic constipation response 66% vs 41% control in meta-analysis
Magnesium	Constipation rescue	moderate	high utility for hard stool / slow transit
Ginger	Nausea / vomiting	mixed-moderate, indirect	possible 10–30% relative nausea/vomiting burden reduction in responders
Electrolytes/ORS	dehydration/fatigue	strong for fluid loss	high utility during vomiting/diarrhea/low intake
Peppermint/caraway	dyspepsia/bloating	moderate, indirect	high utility for functional dyspepsia phenotype
Vitamin D	deficiency/muscle/bone	strong if deficient	high only if deficient
Omega-3	cardiometabolic/inflammation	moderate	not core side-effect tool

---

The Actual BOTB Stack

Tier 1: Essentials

HMB

Best for patients who cannot eat enough protein. Protocol: 3 g/day split into 1 g three times daily. Why: anti-catabolic signal with tiny ingestion burden.

Creatine

Best for preserving training output and strength. Protocol: 3–5 g/day. Why: keeps the mechanical muscle-retention signal alive.

Protein Powder

Best for hitting the amino-acid floor. Protocol: 25–40 g protein per shake, 1–2× daily as needed. Why: substrate still matters.

Psyllium

Best for constipation prevention/control. Protocol: start 3–5 g/day, titrate toward 8–10+ g/day with water. Why: prevents the constipation → reflux → nausea loop.

Electrolytes / ORS

Best for vomiting, diarrhea, low intake, dizziness, fatigue. Protocol: sip during GI symptom windows. Why: prevents dehydration from becoming the hidden reason the patient feels terrible.

---

Tier 2: Symptom-Specific Add-Ons

Ginger

Best for nausea-prone patients. Protocol: 500 mg 1–2× daily.

Magnesium

Best for hard stool / slow transit. Protocol: conservative evening dosing; avoid if diarrhea-prone or kidney-risk.

Peppermint + Caraway

Best for bloating/dyspepsia/upper-GI pressure. Protocol: enteric-coated product before meals; avoid if reflux worsens.

---

Tier 3: Corrective / Secondary

Vitamin D

Use if deficient.

Omega-3

Useful for cardiometabolic support, not primary side-effect mitigation.

---

The Best Stack by Side Effect

If the main problem is nausea

Stack: ginger + electrolytes + small protein feedings + dose hold if needed Expected impact: maybe 10–30% relative reduction in nausea/vomiting burden in responders, extrapolated from non-GLP nausea studies.¹⁰

If the main problem is constipation

Stack: psyllium + fluids + magnesium if hard stool + walking Expected impact: fiber trials show 66% response vs 41% control in chronic constipation; GLP-1-specific effect unknown but highly plausible.⁸

If the main problem is reflux / bloating / dyspepsia

Stack: smaller meals + lower-fat meals + peppermint/caraway if not GERD-dominant Expected impact: moderate-to-high symptom improvement in dyspepsia phenotype, but direct GLP-1 data are lacking.¹⁴

If the main problem is muscle loss

Stack: HMB + creatine + protein floor + resistance training Expected impact: aim to shift lean mass loss from roughly 25% of total weight lost toward 10–20%, depending on training, protein compliance, weight-loss speed, age, and baseline muscle. Tirzepatide body-composition analyses give the 25% lean-mass-loss baseline.⁴

If the main problem is fatigue

Stack: electrolytes + protein + creatine + check calories Expected impact: best when fatigue is driven by low intake, dehydration, or training decline; not a substitute for evaluating anemia, thyroid disease, sleep, depression, or medication issues.

---

Most Important to Remember

The best supplement stack is not the biggest stack.

It is the most bottleneck-matched stack.

If the patient cannot eat, HMB becomes unusually valuable. If the patient cannot train, creatine matters. If the patient cannot poop, psyllium and magnesium matter. If the patient cannot hydrate, ORS matters. If the patient cannot tolerate nausea, ginger is worth trying. If the patient has bloating and upper-GI pressure, peppermint/caraway may fit. If the patient is vitamin D deficient, correct it. If they are not, do not pretend it is magic.

The cleanest GLP-1 supplement architecture is:

HMB + creatine + protein + constipation control + hydration support.

Then personalize from there.

The goal is not to “hack” GLP-1s.

The goal is to make the weight loss more biologically elegant:

more fat lost, less muscle lost, fewer symptoms, better adherence, and a patient who can actually stay on the protocol long enough for the drug to change their life.

---

Related articles

1. Why Optimize?
2. Dosing Protocols (Core Theory Revisited)
3. Highest ROI Medications